tiprankstipranks
Advertisement
Advertisement

JAZZ Stock Latest News

Jazz Pharmaceuticals price target raised to $283 from $280 at Morgan Stanley
The FlyJazz Pharmaceuticals price target raised to $283 from $280 at Morgan Stanley
16h ago
JAZZ
Jazz Pharmaceuticals Buy Rating Reaffirmed as Actio Acquisition Bolsters Rare Epilepsy Pipeline; $300 Price Target Maintained
PremiumRatings
Jazz Pharmaceuticals Buy Rating Reaffirmed as Actio Acquisition Bolsters Rare Epilepsy Pipeline; $300 Price Target Maintained
17h ago
JAZZ
Jazz Pharmaceuticals to Acquire Actio Biosciences in Merger
PremiumCompany Announcements
Jazz Pharmaceuticals to Acquire Actio Biosciences in Merger
1d ago
8K
JAZZ
Jazz Pharmaceuticals: Buy Rating Reiterated as Actio Bioscience Acquisition and ABS-1230 Growth Potential Support Unchanged $307 Price Target
PremiumRatings
Jazz Pharmaceuticals: Buy Rating Reiterated as Actio Bioscience Acquisition and ABS-1230 Growth Potential Support Unchanged $307 Price Target
1d ago
JAZZ
Ami Fadia Reiterates Buy on Jazz Pharmaceuticals, Maintains $292 Price Target Following Actio Biosciences Acquisition
PremiumRatings
Ami Fadia Reiterates Buy on Jazz Pharmaceuticals, Maintains $292 Price Target Following Actio Biosciences Acquisition
2d ago
JAZZ
Jazz Pharmaceuticals to Acquire Rare Epilepsy Specialist Actio
PremiumCompany AnnouncementsJazz Pharmaceuticals to Acquire Rare Epilepsy Specialist Actio
2d ago
8K
JAZZ
Jazz Pharmaceuticals to acquire Actio Biosciences for $820M upfront
Premium
The Fly
Jazz Pharmaceuticals to acquire Actio Biosciences for $820M upfront
2d ago
JAZZ
Jazz Pharmaceuticals to acquire Actio Biosciences for $820M upfront
Premium
The Fly
Jazz Pharmaceuticals to acquire Actio Biosciences for $820M upfront
2d ago
JAZZ
Zymeworks price target raised to $51 from $46 at H.C. Wainwright
PremiumThe Fly
Zymeworks price target raised to $51 from $46 at H.C. Wainwright
6d ago
JNJ
JAZZ
Jazz Pharmaceuticals price target raised to $300 from $290 at Canaccord
PremiumThe Fly
Jazz Pharmaceuticals price target raised to $300 from $290 at Canaccord
7d ago
JAZZ
Jazz Pharmaceuticals Raises Guidance on Q2 Earnings Strength
PremiumCompany Announcements
Jazz Pharmaceuticals Raises Guidance on Q2 Earnings Strength
7d ago
JAZZ
Jazz Pharmaceuticals: Buy Rating Reiterated on Strong Q2 Performance and Oxybate Franchise Momentum; $307 Price Target Maintained
PremiumRatings
Jazz Pharmaceuticals: Buy Rating Reiterated on Strong Q2 Performance and Oxybate Franchise Momentum; $307 Price Target Maintained
8d ago
JAZZ
Jazz Pharmaceuticals: Buy Rating Reaffirmed as Strong Momentum and Emerging Oncology Catalysts Drive Price Target Increase to $280
PremiumRatingsJazz Pharmaceuticals: Buy Rating Reaffirmed as Strong Momentum and Emerging Oncology Catalysts Drive Price Target Increase to $280
8d ago
JAZZ
Jazz Pharmaceuticals: Buy Rating Reaffirmed as Strong Q2 Results, Growth Franchises, and Pipeline Upside Drive Price-Target Increase
Premium
Ratings
Jazz Pharmaceuticals: Buy Rating Reaffirmed as Strong Q2 Results, Growth Franchises, and Pipeline Upside Drive Price-Target Increase
8d ago
JAZZ
Jazz Pharmaceuticals price target raised to $287 from $270 at Deutsche Bank
Premium
The Fly
Jazz Pharmaceuticals price target raised to $287 from $270 at Deutsche Bank
8d ago
JAZZ
Jazz Pharmaceuticals price target raised to $280 from $245 at Morgan Stanley
PremiumThe Fly
Jazz Pharmaceuticals price target raised to $280 from $245 at Morgan Stanley
8d ago
JAZZ
Jazz Pharmaceuticals price target raised to $300 from $275 at TD Cowen
PremiumThe Fly
Jazz Pharmaceuticals price target raised to $300 from $275 at TD Cowen
8d ago
JAZZ
Jazz Pharmaceuticals price target raised to $264 from $254 at Truist
PremiumThe Fly
Jazz Pharmaceuticals price target raised to $264 from $254 at Truist
8d ago
JAZZ
Jazz Pharmaceuticals price target raised to $300 from $285 at Wells Fargo
PremiumThe Fly
Jazz Pharmaceuticals price target raised to $300 from $285 at Wells Fargo
8d ago
JAZZ
Jazz Pharmaceuticals price target raised to $315 from $307 at UBS
PremiumThe FlyJazz Pharmaceuticals price target raised to $315 from $307 at UBS
8d ago
JAZZ
Jazz Pharmaceuticals price target raised to $275 from $230 at Stifel
Premium
The Fly
Jazz Pharmaceuticals price target raised to $275 from $230 at Stifel
8d ago
JAZZ
Jazz Pharmaceuticals price target raised to $276 from $265 at JPMorgan
Premium
The Fly
Jazz Pharmaceuticals price target raised to $276 from $265 at JPMorgan
8d ago
JAZZ

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >